IHS Chemical Week

People & Business :: Companies

Pfizer Completes $68-Billion Wyeth Acquisition

11:21 PM MDT | October 19, 2009 | Deepti Ramesh

Pfizer says it has completed its previously announced acquisition of Wyeth for $68 billion, following the receipt of regulatory approval from all government authorities required by the merger agreement, and approval by Wyeth shareholders. Pfizer agreed to acquire Wyeth in January 2009. Pfizer and Wyeth have begun joint operations from October 16, 2009. The combined company has strengthened capabilities in biotechnology, vaccines, consumer healthcare, nutrition and animal health, and it is expected that no drug will account for more than 10% of the combined...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa